Sulforaphane alleviates hypoxic vestibular vertigo (HVV) by increasing NO production via upregulating the expression of NRF2

Sulforaphane (SFP) treatment represses oxidative stress by activating NRF2. Meanwhile, SFP may also increase the production of nitric oxide (NO) and activate the signaling pathway of cyclic guanosine monophosphate (cGMP), which is involved in the pathogenesis of hypoxic vestibular vertigo (HVV). How...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liyuan, Hu, Changchen, Li, Yujun, Wang, Binquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161921/
https://www.ncbi.nlm.nih.gov/pubmed/35441581
http://dx.doi.org/10.1080/21655979.2022.2030592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161921/
https://www.ncbi.nlm.nih.gov/pubmed/35441581
http://dx.doi.org/10.1080/21655979.2022.2030592

Ejemplares similares